Earnings History Data for ADMA Biologics Inc (ADMA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ADMA Biologics Inc

ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
08-08-2024 AH ADMA ADMA Biologics Inc 2,750 0.13 0.08 -0.02 ADMA Biologics GAAP EPS of $0.13 beats by $0.05, revenue of $107.19M beats by $20.78M
[8/8/2024 4:37 PM]
15.96 3.78 
(30.97%)
14.99 2.80 
(22.97%)
3.06 - 16.64 11,958,290 3,520,000 235,289
09-05-2024 AH ADMA ADMA Biologics Inc 1,580 0.08 0.05 -0.03 ADMA Biologics GAAP EPS of $0.08 beats by $0.02, revenue of $81.9M beats by $4.62M
[5/9/2024 4:23 PM]
8.82 1.89 
(27.34%)
8.22 1.29 
(18.61%)
3.06 - 9.02 10,952,779 2,260,000 240,527
28-02-2024 AH ADMA ADMA Biologics 1,189 0.04 0.02 0.00 ADMA Biologics GAAP EPS of -$0.08 misses by $0.11, revenue of $73.9M beats by $0.93M
[2/28/2024 4:10 PM]
5.36 -0.02 
(-0.46%)
5.31 -0.07 
(-1.30%)
2.94 - 5.72 5,087,435 2,110,000 14,858
08-11-2023 AH ADMA ADMA Biologics Inc 816.41 0.01 -0.01 -0.08 ADMA Biologics GAAP EPS of $0.01, revenue of $67.3M beats by $5.17M
[11/8/2023 4:11 PM]
3.84 0.22 
(6.08%)
3.99 0.37 
(10.22%)
2.47 - 4.65 6,847,000 2,110,000 37,974
09-08-2023 AH ADMA ADMA Biologics Inc 920.21 -0.02 -0.02 -0.07 ADMA Biologics GAAP EPS of -$0.03 in-line, revenue of $60.13M beats by $4.63M
[8/9/2023 4:20 PM]
4.29 0.23 
(5.54%)
4.18 0.12 
(2.96%)
1.99 - 4.64 9,828,844 1,640,000 3,582
10-05-2023 AH 4:05 PM ET
(May 10)
ADMA ADMA Biologics Inc 777.87 -0.03 -0.05 -0.10 ADMA Biologics GAAP EPS of -$0.03 beats by $0.01, revenue of $57M beats by $3.59M
[5/10/2023 4:11 PM]
3.96 0.40 
(11.06%)
3.90 0.33 
(9.24%)
1.43 - 4.03 8,197,139 1,890,000 69,415
23-03-2023 AH 4:05 PM ET
(Mar 23)
ADMA ADMA Biologics Inc 775.37 -0.06 -0.06 -0.09 ADMA Biologics GAAP EPS of -$0.06 beats by $0.01, revenue of $49.95M beats by $1.88M
[3/23/2023 4:06 PM]
3.29 0.18 
(5.63%)
3.33 0.22 
(7.07%)
1.43 - 3.98 3,276,373 3,360,000 48,695
09-11-2022 AH 4:05 PM ET
(Nov 9)
ADMA ADMA Biologics Inc 496.78 -0.08 -0.08 -0.13 ADMA Biologics GAAP EPS of -$0.08 in-line, revenue of $41.09M beats by $6.61M
[11/9/2022 4:17 PM]
3.14 0.67 
(27.13%)
2.74 0.27 
(10.93%)
1.17 - 3.19 14,402,406 2,100,000 26,062
10-08-2022 AH 4:05 PM ET
(Aug 10)
ADMA ADMA Biologics Inc 426.08 -0.07 -0.09 -0.15 ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M
[8/10/2022 4:10 PM]
2.22 0.10 
(4.72%)
2.15 0.03 
(1.42%)
1.01 - 2.48 6,248,891 1,600,000 19,110
11-05-2022 AH 4:05 PM ET
(May 11)
ADMA ADMA Biologics Inc 301.98 -0.10 -0.08 -0.16 ADMA Biologics GAAP EPS of -$0.13 misses by $0.04, revenue of $29.1M beats by $0.95M
[5/11/2022 4:10 PM]
1.68 0.25 
(17.48%)
1.41 -0.02 
(-1.40%)
1.01 - 2.15 3,668,542 3,440,000 13,183
24-03-2022 AH 4:00 PM ET
(Mar 24)
ADMA ADMA Biologics Inc 313.30 -0.09 -0.10 -0.20 ADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61M
[3/24/2022 4:19 PM]
1.62 0.12 
(8.33%)
1.52 0.02 
(1.33%)
1.01 - 2.63 5,288,862 2,019,253 280,408
10-11-2021 AH 4:05 PM ET
(Nov 10)
ADMA ADMA Biologics Inc 266.31 -0.13 -0.15 -0.19 ADMA Biologics EPS beats by $0.01, beats on revenue
[11/10/2021 4:10 PM]
1.58 0.18 
(12.86%)
1.50 0.10 
(7.14%)
1.01 - 3.11 11,638,631 2,190,000 1,005,438
11-08-2021 AH 4:05 PM ET
(Aug 11)
ADMA ADMA Biologics Inc 202.54 -0.15 -0.15 -0.23 ADMA Biologics EPS beats by $0.01, beats on revenue
[8/11/2021 4:18 PM]
1.50 -0.03 
(-1.96%)
1.59 0.06 
(3.92%)
1.38 - 3.71 1,324,835 770,000 45,474
12-05-2021 AH 4:05 PM ET
(May 12)
ADMA ADMA Biologics Inc 214.10 -0.16 -0.17 -0.26 ADMA Biologics EPS beats by $0.01, beats on revenue
[5/12/2021 4:07 PM]
1.62 -0.05 
(-2.99%)
1.71 0.04 
(2.40%)
1.45 - 4.20 3,787,179 5,530,000 24,756
25-03-2021 AH 4:05 PM ET
(Mar 25)
ADMA ADMA Biologics Inc 196.66 -0.20 -0.17 -0.18 ADMA Biologics EPS misses by $0.02, beats on revenue
[3/25/2021 4:08 PM]
1.80 -0.25 
(-12.20%)
1.95 -0.10 
(-4.88%)
1.73 - 4.20 5,703,861 2,950,000 91,132
05-11-2020 AH 4:05 PM ET
(Nov 5)
ADMA ADMA Biologics Inc 179.61 -0.19 -0.20 -0.19 ADMA Biologics EPS beats by $0.01, beats on revenue
[11/5/2020 4:37 PM]
1.90 -0.20 
(-9.72%)
2.06 -0.05 
(-2.37%)
1.45 - 5.23 5,997,754 1,690,095 208,604
06-05-2020 AH ADMA ADMA Biologics Inc 271.12 -0.26 -0.13 -0.31 0.0 0.0 
(0.00%)
0.0 0.0 
(0.00%)
0.0 - 0.0 0 0 0